Tuesday, July 28, 2015 | 8:30 AM - 6:00 PM
Speakers: Marc D Chioda (Pfizer Inc), Leonard James (Pfizer Inc), Iya Khalil (GNS Healthcare), Michael Matheny (Vanderbilt University), Jason H. Moore (University of Pennsylvania), Nicholas Tatonetti (Columbia University Medical Center), Craig P. Webb (NuMedii, Inc), Chunhua Weng (Columbia University)
In the era of precision medicine, analyses of large volumes of data are key to developing targeted and effective therapeutics. This symposium explores how big data and predictive knowledge are used to guide drug development and clinical trials.
Friday, September 18, 2015 | 8:30 AM - 4:30 PM
Speakers: George S. Bloom (University of Virginia), Peter Davies (The Feinstein Institute for Medical Research), Marc I. Diamond (University of Texas, Southwestern Medical Center), Michael Hutton (Eli Lilly and Company), Khalid Iqbal (New York State Institute for Basic Research in Developmental Disabilities), Hartmuth C. Kolb (Johnson & Johnson, Janssen R&D), Nicole Leclerc (Université de Montréal), Richard Ransohoff (Biogen)
Speakers at this symposium will address novel tau-centered mechanisms of neurodegeneration and new therapeutic approaches for many devastating neurological disorders.
October 18 - 22, 2015
Keynote Speakers: Maria Domenica Cappellini (University of Milan) and Stuart H. Orkin (Boston Children's Hospital and Dana-Farber Cancer Institute)
Speakers: Emanuele Angelucci (Cancer Hospital "Armando Businco," Cagliari), Jodie L. Babitt (Massachusetts General Hospital), Jonathan M. Barasch (Columbia University), Daniel E. Bauer (Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School), Sunil Bhandari (Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School), Caterina Borgna-Pignatti (University of Ferrara), Farid Boulad (Memorial Sloan-Kettering Cancer Center), Marina Cavazzana-Calvo (Hospital Necker, University Paris Descartes), David H.K. Chui (Boston University School of Medicine), Thomas D. Coates (Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine), Ann Dean (National Institutes of Health), David Dinan (Nemours Children’s Hospital), Alexander (Hal) Drakesmith (Radcliffe Department of Medicine, University of Oxford), Kathleen Durst (Cooley's Anemia Foundation), Giuliana Ferrari (San Raffaele-Telethon Institute for Gene Therapy), Steven Flamm (Northwestern Medical Center), Mark D. Fleming (Boston Children's Hospital), Ellen B. Fung (UCSF Benioff Children's Hospital Oakland), Andrea Giusti (Galliera Hospital), Olivier Hermine (Hospital Necker, University Paris Descartes), Doug Higgs (University of Oxford), Eldad Arie Hod (Columbia University), Janet L. Kwiatowski (The Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania), Ashutosh (Ash) Lal (University of California San Francisco Benioff Children’s Hospital Oakland), Roberto Machado (University of Illinois College of Medicine), Punam Malik (Cincinnati Children’s Hospital), Jeffery L. Miller (National Institute of Diabetes and Digestive and Kidney Diseases), David G. Nathan (Dana-Farber Cancer Institute), Elizabeth (Ella) Nemeth (University of California, Los Angeles), Ellis Neufeld (Boston Children's Hospital), Arthur Nienhuis (St. Jude Children's Research Hospital), Dudley Pennell (Imperial College London), Antonio Piga (Torino University), John Porter (University College London Hospitals), Stefano Rivella (Children's Hospital of Philadelphia), Thomas M. Ryan (The University of Alabama at Birmingham), Vijay Sankaran (Boston Children's Hospital and Dana-Farber Cancer Institute), Shalini Shenoy (St. Louis Children's Hospital), Ali Taher (American University of Beirut Medical Center), Swee Lay Thein, John F. Tisdale (National Heart, Lung, and Blood Institute), Suzy V. Torti (University of Connecticut Health Center), Tim M. Townes (The University of Alabama at Birmingham), Marsha J. Treadwell (Children's Hospital Oakland), Vip Viprakasit (Siriraj Hospital, Mahidol University), John C. Wood (Children's Hospital Los Angeles)
Global experts explore the biology of globin gene regulation and fetal hemoglobin induction; stem cell transplant, gene therapy strategies, and gene editing; and clinical issues in thalassemia treatment and imaging.
Thursday, June 4, 2015 | 9:00 AM - 5:00 PM
This meeting brings together scientists, policy makers, and international organizations dedicated to advancing our scientific knowledge of HIV and translating that information into the most effective programs for reducing transmission.
Thursday, May 21, 2015 | 9:00 AM - 5:00 PM
Speakers: Marnix Bosch (Northwest Biotherapeutics), Rolf Brekken (University of Texas, Southwestern), Stephen J. Forman (City of Hope), Thomas F. Gajewski (The University of Chicago Medicine), Carl June (University of Pennsylvania), David Kaufman (Merck Research Laboratories), Mark R. Litzow (Mayo Clinic), Andy Minn (University of Pennsylvania), Elaine Pinheiro (Merck Research Laboratories), Robert Vonderheide (University of Pennsylvania)
This symposium will bring together leading experts in immunotherapy and immunology to discuss these emerging approaches, along with the challenges and opportunities faced in this evolving field.
Monday, April 27, 2015 | 8:30 AM - 4:45 PM
Speakers: Erwan Bezard (University of Bordeaux), Patrik Brundin (Van Andel Institute), Marie-Francoise Chesselet (UCLA), Diane G. Cook (Parkinson's Disease Foundation), Maurizio Facheris (The Michael J. Fox Foundation for Parkinson's Research), Horacio Kaufmann (NYU Langone Medical Center), Olivier Rascol (University of Toulouse), Anna Sauerbier (NPF International Centre of Excellence, Kings College London), Daniel Weintraub (University of Pennsylvania)
This symposium will review clinical tools for the diagnosis and treatment of non-motor symptoms of Parkinson's disease, discuss the disease mechanisms, and address preclinical models for the development of new therapeutics.
Thursday, April 16, 2015 | 8:00 AM - 5:00 PM
Keynote Speaker: Frank Hu (Harvard School of Public Health)
Speakers: Brian Bennett (University of North Carolina), Kevin Hall (National Institutes of Health), Rudolph Leibel (Columbia University), Patricia Mabry (National Institutes of Health), Anne McCartney (University of Reading), Christina A. Roberto (Harvard T.H. Chan School of Public Health)
This one-day conference will highlight the connection between nutrition and the complex science of preventing disease. Speakers will focus on promotion of optimal metabolic health, building on input from several complementary disciplines.
Keynote Speaker: Frank Hu (Harvard T.H. Chan School of Public Health)
This eBriefing explores research on metabolic health from several disciplines and looks at how different types of data combine to explain physiology and disease.
Edited by Claudio Carini
Discusses the development of biomarker-based companion diagnostics to optimize diagnosis and treatment choices.
Edited by Matthew E. Fink
(Weill Cornell Medical College), Jack D. Barchas
(Weill Cornell Medical College), and Javaid I. Sheikh
(Weill Cornell Medical College in Qatar)
Discussions of the latest translational research, advanced brain imaging, & novel diagnostics
Edited by Annals of the New York Academy of Sciences
This Annals volume discusses progress in neuroscience that translates to new treatments for psychiatric illness, with a focus on progress in developing quantitative endpoints to measure disease progression and response to therapy in depression and schizophrenia.
A recent conference held at the Academy asked a downright outrageous question: Can dementia be prevented by making changes to your diet? In this podcast we look at what the answers might be.
In the second of a two-part series, experts look at the links between health and nutrition. They examine everything from how nutrition impacts hospital stays, to cancer and aging, to developing food science innovations, and improving diet.
In this first of a two-part series, experts from various sectors explore the available options to reduce "hidden hunger"—micronutrient deficiencies in a population.